BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 14, 2018
View Archived Issues
Mitsubishi Tanabe presents milestones of fourth quarter of fiscal 2017
Read More
First patient dosed in phase II study of eFT-508 plus avelumab in colorectal cancer
Read More
RXi Pharmaceuticals enters research agreement with Iovance Biotherapeutics
Read More
Porcine optic nerve injury model created to study nerve regeneration
Read More
Novel p95HER2-TCB demonstrates efficacy and safety in preclinical models of breast cancer
Read More
Merck & Co. patents KDM5B inhibitors
Read More
Shanghai Pharmaceuticals Holding discloses IDO-1 inhibitors
Read More
Bayer and collaborators identify DHOdehase inhibitors
Read More
BioIncept's PIF-1 designated as orphan drug by FDA for prevention of graft-versus-host-disease
Read More
FDA awards ImmunoGen's IMGN-779 orphan drug designation for AML
Read More
FDA approves Gilenya to treat MS in pediatric patients
Read More
Ono Pharmaceutical reflects on achievements of fourth quarter of fiscal 2017
Read More
Sanofi announces success of initial tender offer for acquisition of Ablynx
Read More
Inovio studies VGX-3100 in new phase II trial for HPV-16 or -18 related anal or peri-anal HSIL
Read More
Phase II trial in China studies SHR-1210 for advanced biliary tract cancer
Read More
Tumor growth inhibition seen with Jubilant Biosys LSD1/HDAC inhibitors
Read More
Medigene and bluebird bio expand TCR alliance
Read More
Human evaluation of CAR T cells targeting ROR1 underway
Read More
Beam Therapeutics launches with focus on creating precision genetic medicines through base editing
Read More
Poseida Therapeutics presents clinical data on P-BCMA-101 for relapsed/refractory multiple myeloma
Read More
Polaris collaborates with MD Anderson Cancer Center to utilize immunotherapy platform
Read More
CS-1003 begins phase I trial in advanced solid tumors
Read More